Show simple item record

dc.contributor.authorBaker, Arabella
dc.contributor.authorThomas, Kim
dc.contributor.authorMitchell, Eleanor
dc.coverage.spatialUK,en_UK
dc.coverage.spatialIsle of Manen_UK
dc.coverage.spatialIrelanden_UK
dc.coverage.spatialUnited States of Americaen_UK
dc.coverage.spatialCanadaen_UK
dc.coverage.spatialMexicoen_UK
dc.coverage.spatialItalyen_UK
dc.coverage.spatialIndiaen_UK
dc.coverage.spatialSingaporeen_UK
dc.coverage.spatialMalaysiaen_UK
dc.coverage.spatialAustraliaen_UK
dc.coverage.spatialSaudi Arabiaen_UK
dc.coverage.spatialSpainen_UK
dc.coverage.spatialSwedenen_UK
dc.coverage.spatialNorwayen_UK
dc.coverage.spatialChileen_UK
dc.date.accessioned2023-03-06T09:08:05Z
dc.date.available2023-03-06T09:08:05Z
dc.date.issued2023-10-01
dc.identifier.urihttps://rdmc.nottingham.ac.uk/handle/internal/10456
dc.description.abstractThe objectives of this study were to evaluate the effect of weekly patient-reported symptom monitoring on participants’ outcomes and to inform the design of future eczema trials on the optimum frequency of outcome assessments. Electronic patient-reported outcome measures were used. All trial processes occurred online, including participant recruitment, eligibility screening, consent, randomisation and data collection through the Research Electronic Data Capture (REDCap©, Vanterbilt University), which is a secure web platform for managing trial data. Recruitment took place through internet-based methods, mainly social media. Individuals who clicked on the advert link were directed to the study website at www.emostudy.org2, which included study aims, eligibility criteria and full participant information. Individuals interested in taking part enrolled through the website. Upon providing informed consent electronically and completing eligibility checks, participants were randomised. After enrolment, participants received an automated welcome email explaining the frequency of data collection, according to their randomised allocation. Email reminders were sent after follow-up questionnaires were overdue by 5 days and 7 days and if still incomplete, a final text reminder with a weblink to the questionnaires was sent.en_UK
dc.language.isoenen_UK
dc.publisherUniversity of Nottinghamen_UK
dc.rightsCC-BY*
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/*
dc.subject.lcshAtopic dermatitisen_UK
dc.subject.lcshClinical trialsen_UK
dc.subject.lcshOutcome assessment (Medical care)en_UK
dc.subject.meshDermatitis, Atopicen_UK
dc.subject.meshRandomized Controlled Trials as Topicen_UK
dc.titleDataset of the Eczema Monitoring Online randomised controlled trialen_UK
dc.identifier.doihttp://doi.org/10.17639/nott.7286
dc.subject.freeatopic eczema, randomised controlled trial, patient reported outcome measuresen_UK
dc.subject.jacsMedicine and Dentistryen_UK
dc.subject.lcR Medicine::RL Dermatologyen_UK
dc.subject.lcW Medicine and related subjects (NLM Classification)::WR Dermatologyen_UK
dc.date.collectionData collection took place between 14 September 2021 and 14 March 2022en_UK
uon.divisionUniversity of Nottingham, UK Campus::Faculty of Medicine and Health Sciences::School of Medicineen_UK
uon.funder.controlledOtheren_UK
uon.datatypePatient-reported questionnaires.en_UK
uon.funder.freeMRC-NIHR Trials Methodology Research Partnership (TMRP) and funding linked to the National Institute for Health and Care Research (NIHR) Senior Investigator award to Professor Hywel Williams.en_UK
uon.collectionmethodElectronic data was collected through the REDCap database, using validated instruments and other eczema related questionnaires.en_UK
uon.legalInformed consent was obtained from all participants prior to data collection. This dataset is anonymised and does not contain any personal identifiable information.en_UK
uon.rightscontactUniversity of Nottinghamen_UK


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

  • Public Research Data
    A collection of research data, held in this repository, that is publicly available, except where individual embargoes apply

Show simple item record

CC-BY
Except where otherwise noted, this item's license is described as Creative Commons by Attribution